➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Colorcon
Harvard Business School
Baxter
Dow
Mallinckrodt

Last Updated: January 16, 2021

DrugPatentWatch Database Preview

Watson Labs Teva Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for WATSON LABS TEVA, and what generic and branded alternatives to WATSON LABS TEVA drugs are available?

WATSON LABS TEVA has forty-nine approved drugs.

There are two tentative approvals on WATSON LABS TEVA drugs.

Summary for Watson Labs Teva
US Patents:0
Tradenames:43
Ingredients:41
NDAs:49

Drugs and US Patents for Watson Labs Teva

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs Teva TERIFLUNOMIDE teriflunomide TABLET;ORAL 209549-001 Jul 27, 2018 DISCN No No   Start Trial   Start Trial
Watson Labs Teva VALSARTAN AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; valsartan TABLET;ORAL 091519-001 Mar 21, 2013 DISCN No No   Start Trial   Start Trial
Watson Labs Teva TEMOZOLOMIDE temozolomide CAPSULE;ORAL 203959-001 Apr 18, 2017 AB RX No No   Start Trial   Start Trial
Watson Labs Teva BUPRENORPHINE buprenorphine FILM, EXTENDED RELEASE;TRANSDERMAL 204937-004 Nov 20, 2018 AB RX No No   Start Trial   Start Trial
Watson Labs Teva NORETHINDRONE AND ETHINYL ESTRADIOL (10/11) ethinyl estradiol; norethindrone TABLET;ORAL-28 071044-001 Apr 1, 1988 RX No No   Start Trial   Start Trial
Watson Labs Teva NAPROXEN naproxen TABLET;ORAL 074163-003 Feb 10, 1995 DISCN No No   Start Trial   Start Trial
Watson Labs Teva TEMOZOLOMIDE temozolomide CAPSULE;ORAL 203959-003 Apr 18, 2017 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
McKesson
Mallinckrodt
Merck
Boehringer Ingelheim
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.